[1] 朱世超, 郑学敏, 张 玥, 等. 法尼醇X 受体激动剂奥贝胆酸[J]. 现代药物与临床, 2016, 31(3): 396—400.

[2] US FDA. Ocaliva (obeticholic acid) tablet label[EB/OL] .[ 2016-05-27] . http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207999s000lbl.pdf

[3] 卓 超, 吴达俊, 沈平孃, 等. 熊去氧胆酸的制备方法: 中国, 1308085 [P]. 2001-08-15.

[4] Uekawa T, Ishigami K, Kitahara T. Short-step synthesis of chenodiol from stigmasterol [J]. Biosci Biotechnol Biochem, 2004, 68(6): 1332—1337.

[5] 蒋忠良, 宗 杰, 段 辉, 等. 一种3α,7α- 二羟基-5β- 胆烷酸的制备方法: 中国, 101434632 [P]. 2009-05-20.

[6] 闫学斌, 张建业, 王庆录, 等. 一种鹅去氧胆酸的合成方法: 中国, 102060902 [P]. 2011-05-18.

[7] 庄治平, 陈 英, 周维善. 5β,3α- 羟基-7- 羰基- 胆烷酸的还原反应[J]. 有机化学, 1986, 6(4): 281—285.

[8] 张国明, 余晓岚, 严崇萍. NBS 氧化制备熊去氧胆酸中间体7- 氧代石胆酸[J] . 中国医药工业杂志, 1996, 27(5) :234.

[9] Yu DD, Forman BM. Novel method of synthesizing alkylated bile acid derivatives: US, 2009062526 [P]. 2009-03-05.

[10] Yu D, Mattern DL, Forman BM. An improved synthesis of 6α-ethylchenodeoxycholic acid (6ECDCA), a potent and selective agonist for the Farnesoid X Receptor(FXR) [J]. Steroids, 2012, 77(13): 1335—1338.

[11] Königsberger K, Chen GP, Vivelo J, et al. An expedient synthesis of 6α-fluoroursodeoxycholic acid [J]. Org Proc Res Dev, 2002, 6(5): 665—669.

[12] Sepe V, Ummarino R, D'Auria MV, et al. Conicasterol E, a small heterodimer partner sparing farnesoid X receptor modulator endowed with a pregnane X receptor agonistic activity, from the marine sponge theonella swinhoei [J]. J Med Chem, 2012, 55(1): 84—93.

[13] D'Amore C, Di LF, Sepe V, et al. Design, synthesis, and biological evaluation of potent dual agonists of nuclear and membrane bile acid receptors [J]. J Med Chem, 2014, 57(3):937—954.

[14] Ferrari M, Zinetti F. Process for preparing high purity ursodeoxycholic acid: WO, 2014020024 [P]. 2014-02-06.

[15] 姚凤云. 用含量86% 的鹅去氧胆酸生产熊去氧胆酸的生产方法: 中国, 101215311 [P]. 2008-07-09.                                                                                                                                                          [16] Pedrini P, Andreotti E, Guerrini A, et al. Xanthomonas maltophilia CBS 897.97 as a source of new 7β- and 7α-hydroxysteroid dehydrogenases and cholylglycine hydrolase: improved biotransformations of bile acids [J]. Steroids, 2006, 71(3): 189—198.

[17] Giovannini PP, Grandini A, Perrone D, et al. 7α- and 12α-Hydroxysteroid dehydrogenases from acinetobacter calcoaceticus lwoffii: a new integrated chemo-enzymatic route to ursodeoxycholic acid [J]. Steroids, 2008, 73(14): 1385—1390.

[18] Fantin G, Ferrarini S, Medici A, et al. Regioselective microbial oxidation of bile acids [J]. Tetrahedron, 1998, 54(9): 1937—1942.

[19] Pellicciari R, Fiorucci S, Camaioni E, et al. 6α-Ethylchenodeoxycholic acid(6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity [J]. J Med Chem, 2002, 45(17): 3569—3572.

[20] Pellicciari R. Steroids as agonists For FXR: WO, 02072598 [P]. 2002-09-19.

[21] 张 胜. 一种奥贝胆酸的制备方法: 中国, 104926909 [P].2015-09-23.

[22] 马西莫· 法拉利, 罗伯托· 佩里恰里. 制备3α( β) -7α( β) - 二羟基-6α( β) - 烷基-5β- 胆烷酸的方法: 中国,101203526 [P]. 2008-06-18.

[23] 施泰纳A, 维纳伦德普尔森H, 乔利博瓦E, 等. 奥贝胆酸的制备、用途和固体形式: 中国, 104781272 [P] .2015-07-15.

[24] Gioiello A, Macchiarulo A, Pellicciari R, et al. Extending SAR o f b i l e a c i d s a s FXR l i g a n d s : d i s c o v e r y o f 23-N-(carbocinnamyloxy) -3α,7α-dihydroxy-6α-ethyl-24-nor-5β-cholan-23-amine [J]. Bioorg Med Chem, 2011,19(8): 2650-2658.

[25] 邱玥珩, 曹忠诚, 强晓明, 等. 奥贝胆酸及其有关物质的合成[J]. 中国医药工业杂志, 2016, 47(4): 376—379.

[26] 任文杰, 郑德强, 刘文涛, 等. 一种制备奥贝胆酸的方法:中国, 105315320 [P]. 2016-02-10.